Schedule 13G ownership disclosure

SCPHARMACEUTICALS INC

Common Stock · CUSIP: 810648105

Event date: 2025-03-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Luther King Capital Management Corporation

    Shares: 3,121,170 · Class: 6.2%

  • J. Luther King, Jr.

    Shares: 3,249,170 · Class: 6.5%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000950170-25-059275
Form type
SCHEDULE 13G/A
Filer
KING LUTHER CAPITAL MANAGEMENT CORP
CIK
CIK 310051
Filed
Apr 28, 2025
Reporting period
Mar 31, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub